Key result
The abstract reports clinical experience from the RIETE registry concerning the relationship between different platelet values and bleeding risk in VTE patients on anticoagulants, without providing quantitative results.
Why the study?
Major bleeding is a dangerous complication of anticoagulant treatment for VTE, and risk scores commonly consider platelet count, particularly thrombocytopenia.
Does platelet count affect the risk of bleeding in patients receiving anticoagulant therapy for venous thromboembolism?
Population
Patients receiving anticoagulant treatment for VTE in the RIETE registry
Comparison
Different values of platelets
Design
Registry-based study
Authors
Loading...
Should not yet guide platelet-based anticoagulation adjustments in VTE; hypothesis-generating observational data needing prospective validation.
Observational
Does platelet count affect the risk of bleeding in patients receiving anticoagulant therapy for venous thromboembolism?
This paper reports clinical experience from the RIETE registry regarding the relationship between platelet count and bleeding risk in VTE patients on anticoagulation, though specific results are not provided in the abstract.
Micco et al. (2020) conducted an observational in Venous Thromboembolism (VTE). Different values of platelets was evaluated on Risk of bleeding. The abstract reports clinical experience from the RIETE registry concerning the relationship between different platelet values and bleeding risk in VTE patients on anticoagulants, without providing quantitative results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: